EE04737B1 - Kompositsioonid arteriaalse tromboosi ärahoidmiseks ja raviks ning Xa faktori inhibiitori kasutamine iseseisvalt ja/või kombineeritult vereliistakuteagregeerumise vastase toimeainega - Google Patents

Kompositsioonid arteriaalse tromboosi ärahoidmiseks ja raviks ning Xa faktori inhibiitori kasutamine iseseisvalt ja/või kombineeritult vereliistakuteagregeerumise vastase toimeainega

Info

Publication number
EE04737B1
EE04737B1 EEP199900574A EEP9900574A EE04737B1 EE 04737 B1 EE04737 B1 EE 04737B1 EE P199900574 A EEP199900574 A EE P199900574A EE P9900574 A EEP9900574 A EE P9900574A EE 04737 B1 EE04737 B1 EE 04737B1
Authority
EE
Estonia
Prior art keywords
prevention
compositions
factor
treatment
combination
Prior art date
Application number
EEP199900574A
Other languages
English (en)
Estonian (et)
Inventor
Bernat Andr�
Herbert Jean-Marc
Petitou Maurice
Van Amsterdam Ronald
Original Assignee
Sanofi-Synthlabo
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthlabo, Akzo Nobel N.V. filed Critical Sanofi-Synthlabo
Publication of EE9900574A publication Critical patent/EE9900574A/xx
Publication of EE04737B1 publication Critical patent/EE04737B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP199900574A 1997-06-13 1998-06-09 Kompositsioonid arteriaalse tromboosi ärahoidmiseks ja raviks ning Xa faktori inhibiitori kasutamine iseseisvalt ja/või kombineeritult vereliistakuteagregeerumise vastase toimeainega EE04737B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9707368A FR2764511B1 (fr) 1997-06-13 1997-06-13 Compositions pour le traitement et la prevention de la thrombose arterielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinaison avec un antiagregant plaquettaire
PCT/FR1998/001172 WO1998056365A1 (fr) 1997-06-13 1998-06-09 INHIBITEUR DU FACTEUR Xa SEUL OU EN COMBINAISON AVEC UN ANTIAGREGANT PLAQUETTAIRE, CONTRE LA THROMBOSE ARTERIELLE

Publications (2)

Publication Number Publication Date
EE9900574A EE9900574A (et) 2000-08-15
EE04737B1 true EE04737B1 (et) 2006-12-15

Family

ID=9507960

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900574A EE04737B1 (et) 1997-06-13 1998-06-09 Kompositsioonid arteriaalse tromboosi ärahoidmiseks ja raviks ning Xa faktori inhibiitori kasutamine iseseisvalt ja/või kombineeritult vereliistakuteagregeerumise vastase toimeainega

Country Status (43)

Country Link
US (2) US6541488B1 (pt)
EP (1) EP0986376B1 (pt)
JP (1) JP3988803B2 (pt)
KR (1) KR100598451B1 (pt)
CN (1) CN1253150C (pt)
AR (1) AR012247A1 (pt)
AT (1) ATE384528T1 (pt)
AU (1) AU728826B2 (pt)
BR (1) BR9810520A (pt)
CA (1) CA2293415C (pt)
CO (1) CO4940476A1 (pt)
CY (1) CY1107912T1 (pt)
CZ (1) CZ299518B6 (pt)
DE (1) DE69839046T2 (pt)
DK (1) DK0986376T3 (pt)
DZ (1) DZ2512A1 (pt)
EE (1) EE04737B1 (pt)
ES (1) ES2299209T3 (pt)
FR (1) FR2764511B1 (pt)
GT (1) GT199800171A (pt)
HK (1) HK1032750A1 (pt)
HR (1) HRP980322B1 (pt)
HU (1) HU227956B1 (pt)
ID (1) ID29309A (pt)
IL (1) IL133452A (pt)
IS (1) IS2619B (pt)
ME (1) ME00685B (pt)
MY (1) MY124648A (pt)
NO (1) NO323739B1 (pt)
NZ (1) NZ501452A (pt)
PL (1) PL193405B1 (pt)
PT (1) PT986376E (pt)
RS (1) RS49902B (pt)
RU (1) RU2212886C2 (pt)
SA (1) SA98190552B1 (pt)
SI (1) SI0986376T1 (pt)
SK (1) SK286311B6 (pt)
TR (1) TR199903087T2 (pt)
TW (1) TW565442B (pt)
UA (1) UA70919C2 (pt)
UY (1) UY25044A1 (pt)
WO (1) WO1998056365A1 (pt)
ZA (1) ZA985137B (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2764511B1 (fr) * 1997-06-13 2000-09-08 Sanofi Sa Compositions pour le traitement et la prevention de la thrombose arterielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinaison avec un antiagregant plaquettaire
CA2360305A1 (en) 1999-02-09 2000-08-17 Bristol-Myers Squibb Company Lactam inhibitors of fxa and method
US6344450B1 (en) 1999-02-09 2002-02-05 Bristol-Myers Squibb Company Lactam compounds and their use as inhibitors of serine proteases and method
FR2793687B1 (fr) * 1999-04-26 2001-08-24 Sanofi Sa Nouvelle composition injectable d'un anticoagulant
FR2800074B1 (fr) * 1999-10-22 2001-12-21 Aventis Pharma Sa Nouveaux oligosaccharides, leur preparation et les compositions pharmaceutiques les contenant
US6544981B2 (en) 2000-06-09 2003-04-08 Bristol-Myers Squibb Company Lactam inhibitors of factor Xa and method
US6511973B2 (en) 2000-08-02 2003-01-28 Bristol-Myers Squibb Co. Lactam inhibitors of FXa and method
DE60217835D1 (en) * 2001-02-28 2007-03-15 John H Griffin Plasmaglucosylceramiddefizienz als risikofaktor für thrombose und modulator von anticoagulant protein c
UA80399C2 (en) * 2001-11-13 2007-09-25 Glaxo Group Ltd Use of specific dose of fondaparinux sodium for the treatment of acs
US20040067995A1 (en) 2002-10-02 2004-04-08 Wong Pancras C. Novel combination of a factor Xa inhibitor and clopidogrel
WO2004048363A1 (ja) * 2002-11-22 2004-06-10 Takeda Pharmaceutical Company Limited イミダゾール誘導体、その製造法および用途
EP1679067A4 (en) * 2003-09-19 2010-04-07 Kissei Pharmaceutical COMBINED MEDICINES
WO2005087266A1 (en) * 2004-03-05 2005-09-22 Vddi Pharmaceuticals Combination therapy for inhibition of platelet aggregation
KR101099884B1 (ko) * 2004-04-23 2011-12-28 히또시 기야 동화상데이터의 부호화방법, 복호화방법, 이들을 실행하는단말장치, 및 쌍방향 대화형 시스템
TWI396686B (zh) 2004-05-21 2013-05-21 Takeda Pharmaceutical 環狀醯胺衍生物、以及其製品和用法
US7563780B1 (en) * 2004-06-18 2009-07-21 Advanced Cardiovascular Systems, Inc. Heparin prodrugs and drug delivery stents formed therefrom
JP5557410B2 (ja) * 2004-07-13 2014-07-23 第一三共株式会社 経口投与による血栓・塞栓の予防治療剤
US20070105825A1 (en) * 2004-09-16 2007-05-10 Yuji Hoyano Concurrent drugs
EP1991272A2 (en) * 2005-10-10 2008-11-19 N.V. Organon Antithrombotic compound
EP2323605A4 (en) * 2008-09-10 2014-02-05 Syneron Medical Ltd TRANSDERMAL RELEASE OF OLIGOSACCHARIDES
WO2011149110A1 (en) 2010-05-28 2011-12-01 Daiichi Sankyo Company, Limited Novel composition for the prevention and/or treatment of thromboembolism
WO2016066128A1 (zh) * 2014-10-30 2016-05-06 成都百裕科技制药有限公司 一种含有银杏内酯B和Xa因子抑制剂的药物组合物及其制备方法和用途
CN106860868B (zh) * 2015-12-11 2019-11-22 北京百奥药业有限责任公司 沙班类药物与蚓激酶的药物组合物、制剂及其应用
US11654036B2 (en) 2020-05-26 2023-05-23 Elixir Medical Corporation Anticoagulant compounds and methods and devices for their use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2548189B1 (fr) * 1983-07-01 1986-04-11 Choay Sa Nouveaux produits contenant des oligosaccharides, leur preparation et leurs applications biologiques et biochimiques
ZA928276B (en) 1991-10-31 1993-05-06 Daiichi Seiyaku Co Aromatic amidine derivates and salts thereof.
FR2728901B1 (fr) * 1994-12-28 1997-03-28 Sanofi Sa Derives de phenyl-4-thiazoles substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
IL129877A (en) 1996-11-27 2004-08-31 Aventis Pharm Prod Inc A pharmaceutical preparation containing a component having an Xa antagonist activity and an antifouling agent
FR2764511B1 (fr) * 1997-06-13 2000-09-08 Sanofi Sa Compositions pour le traitement et la prevention de la thrombose arterielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinaison avec un antiagregant plaquettaire

Also Published As

Publication number Publication date
HU227956B1 (en) 2012-07-30
ME00685B (me) 2008-08-07
CN1253150C (zh) 2006-04-26
JP2002504110A (ja) 2002-02-05
NO996137L (no) 2000-02-14
IS2619B (is) 2010-05-15
YU63699A (sh) 2002-06-19
CY1107912T1 (el) 2013-09-04
KR20010013690A (ko) 2001-02-26
US6541488B1 (en) 2003-04-01
SA98190552B1 (ar) 2006-09-09
FR2764511B1 (fr) 2000-09-08
NO323739B1 (no) 2007-07-02
ATE384528T1 (de) 2008-02-15
SK170999A3 (en) 2000-07-11
DZ2512A1 (fr) 2003-02-01
CA2293415C (en) 2011-08-09
HUP0002175A3 (en) 2003-05-28
IL133452A0 (en) 2001-04-30
GT199800171A (es) 2000-04-21
CZ446099A3 (cs) 2000-04-12
CO4940476A1 (es) 2000-07-24
ES2299209T3 (es) 2008-05-16
ZA985137B (en) 1999-01-07
PT986376E (pt) 2008-04-01
HRP980322A2 (en) 1999-04-30
TR199903087T2 (xx) 2000-05-22
IS5280A (is) 1999-11-30
SK286311B6 (en) 2008-07-07
RU2212886C2 (ru) 2003-09-27
UY25044A1 (es) 2000-10-31
TW565442B (en) 2003-12-11
EP0986376B1 (fr) 2008-01-23
NZ501452A (en) 2002-06-28
NO996137D0 (no) 1999-12-10
HRP980322B1 (en) 2003-12-31
IL133452A (en) 2004-09-27
ID29309A (id) 2001-08-16
PL193405B1 (pl) 2007-02-28
RS49902B (sr) 2008-08-07
HK1032750A1 (en) 2001-08-03
WO1998056365A1 (fr) 1998-12-17
DK0986376T3 (da) 2008-05-13
CZ299518B6 (cs) 2008-08-20
MY124648A (en) 2006-06-30
SI0986376T1 (sl) 2008-06-30
AU728826B2 (en) 2001-01-18
EE9900574A (et) 2000-08-15
CA2293415A1 (en) 1998-12-17
JP3988803B2 (ja) 2007-10-10
CN1274281A (zh) 2000-11-22
US20040092477A1 (en) 2004-05-13
PL337288A1 (en) 2000-08-14
HUP0002175A1 (hu) 2000-11-28
UA70919C2 (uk) 2004-11-15
DE69839046D1 (de) 2008-03-13
EP0986376A1 (fr) 2000-03-22
AU7924698A (en) 1998-12-30
DE69839046T2 (de) 2009-01-15
AR012247A1 (es) 2000-09-27
KR100598451B1 (ko) 2006-07-10
BR9810520A (pt) 2000-09-19
FR2764511A1 (fr) 1998-12-18

Similar Documents

Publication Publication Date Title
EE04737B1 (et) Kompositsioonid arteriaalse tromboosi ärahoidmiseks ja raviks ning Xa faktori inhibiitori kasutamine iseseisvalt ja/või kombineeritult vereliistakuteagregeerumise vastase toimeainega
NZ297118A (en) Antithrombotic formulation; comprises thrombin inhibitor and one or more absorption enhancing agents
DE69836008D1 (de) Zusammensetzung und behandlungsmittel
NO961223L (no) Öket korrosjonsbeskyttelse ved bruk av friksjonsreduksjonsmidler i forbindelse med korrosjonsinhibitorer
IS5341A (is) Samsett meðferð sem inniheldur atórvastatin og þrýstingslækkandi miðil
DE69519672D1 (de) Synergistische tensidzusammensetzungen und konzentrate davon zur feuerbekämpfung
DE69607321D1 (de) Reinigungsverfahren und zusammensetzung
PL335166A1 (en) Synergic combination of sulphonylurea and glytazone
ID24196A (id) Komposisi dan penggunaan
EE9800339A (et) Aminoisokinoliinid ja aminotienopüridiini derivaadid ning nende kasutamine põletikuvastaste ainetena
DE69918842D1 (de) Desinfektionszusammensetzungen und verfahren
DE69725625D1 (de) Reinigungs- und/oder desinfektionsmittel
DE69620642D1 (de) Reiningungsverfahren und-zusammensetzung
BR9500630A (pt) Composição absorvente sólida e artigo fabricado incluindo uma composição absorvente sólida
NZ332757A (en) Substituted tetrahydroisoquinoline benzamide derivatives and their use as anticonvulsants and psycho-active agents
DE69919340D1 (de) Überzugszusammensetzungen und verfahren
IL131085A0 (en) The use of levobupivacaine or ropivacaine in treating migraine
PT984777E (pt) Piperazinas arilsubstituidas uteis no tratamento da hiperplasia benigna da prostata
ID18852A (id) Komposisi-komposisi dan barang-barang manufaktur
DE69831059D1 (de) Azeotropische oder azeotropähnliche zusammensetzungen und ihre verwendungen
NO20006626D0 (no) Beleggingsmiddel og anvendelse herav
AU7688998A (en) Use of metalloproteinase inhibitors in the treatment and prevention of pulmonaryemphysema
DE59711418D1 (de) Pulverförmige Wasch- und Reinigungsmittel-Komponente
KR960004703U (ko) 컵받침 겸 컨솔 도어
KR950029445U (ko) 배추의 절임 및 세척장치

Legal Events

Date Code Title Description
GB1A Change in the ownership or in the address of the owner
HC1A Change of owner name
HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231